Modified release of furosemide from Eudragits® and poly(ethylene oxide)-based matrices and dry-coated tablets Cover

.blurhash-client-img { display: none !important; }

Modified release of furosemide from Eudragits® and poly(ethylene oxide)-based matrices and dry-coated tablets

Acta Pharmaceutica

Volume 70 (2020): Issue 1 (March 2020)

By: Marilena Vlachou, Efthymia Geraniou and Angeliki Siamidi

Open Access

|Nov 2019

Authors

Marilena Vlachou

vlachou@pharm.uoa.gr

Section of Pharmaceutical Technology, Department of Pharmacy, School of Health Sciences, National and Kapodistrian University of Athens

Efthymia Geraniou

Section of Pharmaceutical Technology, Department of Pharmacy, School of Health Sciences, National and Kapodistrian University of Athens

Angeliki Siamidi

Section of Pharmaceutical Technology, Department of Pharmacy, School of Health Sciences, National and Kapodistrian University of Athens

DOI: https://doi.org/10.2478/acph-2020-0010 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075

Journal RSS Feed

Language: English

Page range: 49 - 61

Accepted on: Apr 4, 2019

Published on: Nov 1, 2019

Published by: Croatian Pharmaceutical Society

In partnership with: Paradigm Publishing Services

Publication frequency: 4 issues per year

Keywords:

matrix tablets,

compression coated tablets,

poly(ethylene oxide),

polyvinylpyrrolidone

Related subjects:

Pharmacy, other

© 2019 Marilena Vlachou, Efthymia Geraniou, Angeliki Siamidi, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous article Volume 70 (2020): Issue 1 (March 2020)Next article